PRCT - PROCEPT BioRobotics Corp


23.03
-1.060   -4.603%

Share volume: 1,368,594
Last Updated: 04-28-2026
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: -0.05%

PREVIOUS CLOSE
CHG
CHG%

$24.09
-1.06
-0.04%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
39%
Profitability 35%
Dept financing 30%
Liquidity 75%
Performance 36%
Company vs Stock growth
vs
Performance
5 Days
-5.46%
1 Month
-9.86%
3 Months
-20.91%
6 Months
-35.90%
1 Year
-59.10%
2 Year
-55.75%
Key data
Stock price
$23.03
P/E Ratio 
0.00
DAY RANGE
$22.52 - $24.45
EPS 
-$1.71
52 WEEK RANGE
$19.35 - $66.85
52 WEEK CHANGE
-$57.34
MARKET CAP 
1.758 B
YIELD 
N/A
SHARES OUTSTANDING 
56.390 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
07-31-2025
BETA 
0.67
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$1,176,010
AVERAGE 30 VOLUME 
$1,206,918
Company detail
CEO: Reza Zadno
Region: US
Website: procept-biorobotics.com
Employees: 430
IPO year: 2021
Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in Redwood City, California. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery.

Recent news